Related Experiment Video
Updated: Mar 10, 2026
06:07
Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
Published on: June 7, 2020
5.4K
Estrogen Receptor β as a Pharmaceutical Target
Margaret Warner1, Bo Huang1, Jan-Ake Gustafsson2
1Center for Nuclear Receptors and Cell Signaling, Department of Cell Biology and Biochemistry, University of Houston, Texas, USA.
Trends in Pharmacological Sciences
|December 17, 2016
Summary
Developing precise hormone therapies is crucial for maximizing health benefits and minimizing side effects. Selective targeting of hormone receptor subtypes, like estrogen receptor beta (ERβ), offers a promising approach for safer treatments.
Area of Science:
- Endocrinology
- Pharmacology
- Molecular Biology
Background:
- Hormone therapies offer significant health benefits but often cause adverse effects.
- Developing precise medicines to selectively target hormone actions remains a major clinical challenge.
- This challenge is particularly relevant for nuclear receptor ligands, including hormones like estrogen.
Purpose of the Study:
- To explore the potential of selective estrogen receptor beta (ERβ) targeting.
- To investigate ERβ as a precise therapeutic target for various conditions.
- To reduce side effects associated with traditional hormone therapies.
Main Methods:
- Focus on selective targeting of estrogen receptor beta (ERβ) subtypes.
- Review of current research on ERβ's role in hormone replacement and cancer.
- Analysis of strategies for harnessing ERβ's beneficial effects while mitigating risks.
Main Results:
- Selective targeting of ERβ presents a viable strategy for hormone therapy.
- ERβ shows promise as a target for hormone replacement therapy.
- ERβ is a potential target for treating breast and prostate cancers.
Conclusions:
- Selective targeting of ERβ is a key strategy for developing precise endocrine medicines.
- ERβ-selective therapies could offer improved treatment outcomes with fewer side effects.
- Further research into ERβ modulation holds significant therapeutic potential in endocrinology and oncology.
More Related Videos
Related Concept Videos
01:31Transducer Mechanism: Nuclear Receptors
4.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
4.3K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.6K
01:15G Protein-coupled Receptors
18.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.6K
02:38Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
60
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
01:31Internal Receptors
75.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
75.7K